School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Department of Cardiovascular Surgery, Asia University Hospital, Taichung 40201, Taiwan.
Biomolecules. 2020 Feb 5;10(2):244. doi: 10.3390/biom10020244.
Hyperlipidemia is one of the strong risk factors for ischemic heart disease. Using the Taiwan Biobank (TWB) database, we evaluated the risk of hyperlipidemia and its interaction with sex and rs688 polymorphism on the low-density lipoprotein receptor (LDLR) gene. Data collection in the biobank started in 2008 and is ongoing. Data analysis was performed on the participants' data collected between 2008 and 2015. In general, 27.92% of the 9237 female participants and 32.65% of the 8690 male participants were identified with hyperlipidemia. Compared to the C/C genotype, C/T and T/T genotypes were not significant risk factors for hyperlipidemia (OR = 1.061, CI: 0.976-1.153 for C/T and OR = 1.052, CI: 0.845-1.309 for T/T genotype) in the general model. However, there was a significant interaction between sex and rs6888 on hyperlipidemia risk (p-interaction = 0.0321). With the male sex/CC genotype being the reference group, only the female sex/CT and T/T genotypes were closely associated with hyperlipidemia, with respective ORs of 1.153 (CI: 1.014-1.311) and 1.423 (CI: 1.056-1.917). Our data indicate that rs688 C/T and T/T genotypes may be associated with increased risk of hyperlipidemia in Taiwanese women. These findings may be relevant in lipid-modification therapy.
高脂血症是缺血性心脏病的一个重要危险因素。我们利用台湾生物银行(TWB)数据库,评估了高脂血症的风险及其与性别和低密度脂蛋白受体(LDLR)基因 rs688 多态性的相互作用。该生物银行的数据收集始于 2008 年,目前仍在进行中。数据分析基于 2008 年至 2015 年间收集的参与者数据。一般来说,9237 名女性参与者中有 27.92%和 8690 名男性参与者中有 32.65%被诊断为高脂血症。与 C/C 基因型相比,C/T 和 T/T 基因型不是高脂血症的显著危险因素(C/T 基因型的 OR = 1.061,CI:0.976-1.153;T/T 基因型的 OR = 1.052,CI:0.845-1.309)。然而,性别和 rs6888 之间存在显著的交互作用(p 交互 = 0.0321)。以男性/CC 基因型为参照组,仅女性/CT 和 T/T 基因型与高脂血症密切相关,OR 分别为 1.153(CI:1.014-1.311)和 1.423(CI:1.056-1.917)。我们的数据表明,rs688 C/T 和 T/T 基因型可能与台湾女性高脂血症风险增加相关。这些发现可能与脂质修饰治疗有关。